Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...
Thermo Fisher Scientific Inc. ( NYSE:TMO ) shareholders might be concerned after seeing the share price drop 10% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback